The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998

Himmelmann, Kate; Hagberg, G; Beckung, Eva; Hagberg, B; Uvebrant, Paul

doi:10.1111/j.1651-2227.2005.tb03071.x

Cited by 374 publications

(274 citation statements)

References 32 publications

Supporting

Mentioning

241

Contrasting

Unclassified

Order By: Relevance

“…[4,[14][15][16][17] However, a small increase was reported in USA between 1975 and 1991 [18] while in Sweden the monitoring from the 1950s to the 1990s showed an increase in prevalence from the beginning of the 1970s to the mid 1980s followed by a decrease. [19] Also, in Iceland a decrease in prevalence for term babies was observed in 1997-2003 in comparison with [1990][1991][1992][1993][1994][1995][1996]. [20] In 1998, a network of population-based CP registers, Surveillance of Cerebral Palsy in Europe (SCPE), [21] was established.…”

Section: Introductionmentioning

confidence: 99%

Trends in prevalence of cerebral palsy in children born with a birthweight of 2,500 g or over in Europe from 1980 to 1998

et al. 2010

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Trends in prevalence of cerebral palsy in children born with a birthweight of 2,500 g or over in Europe from 1980 to 1998

et al. 2010

View full text Add to dashboard Cite

“…It is the most frequent cause of motor disability amongst children in Europe [2]. The prevalence in Europe has been rather stable over the last 30 years and ranges between 1.5 and 3.0 per 1,000 live births [3].…”

Section: Introductionmentioning

confidence: 99%

The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb

Molenaers

Campenhout

Fagard³

et al. 2010

Journal of Children's Orthopaedics

View full text Add to dashboard Cite

Purpose The purpose of this review is to clarify the role of botulinum toxin serotype A (BTX-A) in the treatment of children with cerebral palsy (CP), with a special focus on the lower limb. Background The treatment of spasticity is central in the clinical management of children with CP. BTX-A blocks the release of acetylcholine at the motor end plate, causing a temporary muscular denervation and, in an indirect way, a reduced spasticity. Children with increased tone develop secondary problems over time, such as muscle contractures and bony deformities, which impair their function and which need orthopaedic surgery. However in these younger children, delaying surgery is crucial because the results of early surgical interventions are less predictable and have a higher risk of failure and relapse. As BTX-A treatment reduces tone in a selective way, it allows a better motor control and muscle balance across joints, resulting in an improved range of motion and potential to strengthen antagonist muscles, when started at a young age. The effects are even more obvious when the correct BTX-A application is combined with other conservative therapies, such as physiotherapy, orthotic management and casts. There is now clear evidence that the consequences of persistent increased muscle tone can be limited by applying an integrated multi-level BTX-A treatment approach. Nevertheless, important challenges such as patient selection, defining appropriate individual goals, timing, dosing and dilution, accuracy of injection technique and how to measure outcomes will be questioned. Therefore, ''reflection is more important than injection'' remains an actual statement.

show abstract

“…Our study found the commonest presentation of cerebral palsy to be spastic CP found in 90.2% of the sample followed by atonic (3.9%) and ataxic/mixed CP (3.9%).The other Pakistani study carried out by Nazir B et al found 72% of all CP children to be having spastic CP followed by atonic CP (19%) and athetoid CP (6.7%) 6 . Nafi OA, Tosun A, Himmelmann K, Wichers MJ and Winter S also reported commonest presentation of cerebral palsy as spastic type in Jordanian, Turkish, Swedish, Dutch and American population 11,10,5,12,13,14 . Diplegia was the commonest presentation of spastic CP in our study, found in 33.3%.…”

Section: Discussionmentioning

confidence: 99%

Pakistanlı Çocuklarda Serebral Palsi: Hastane Tabanlı İnceleme

Khan¹,

Kazemi²,

Ayaz³

et al. 2014

Cukurova Medical Journal

View full text Add to dashboard Cite

Purpose: The prevalence of cerebral palsy is high in Pakistan, however, it needs to be further explored. This study aimed at assessing clinical presentations and etiological factors among children with cerebral palsy in a Pakistani hospital. Materials and Methods:It was a descriptive case series recruiting 102 children who presented to cerebral palsy rehabilitation clinic of Armed Forces Institute of Rehabilitation Medicine, Rawalpindi fulfilling the criteria adopted by Surveillance of Cerebral Palsy in Europe. Results:Of 102 children, 46 (45.1%) were male and 56 (54.9%) were female with a mean age of 5.6 ± 2.25 years.Spastic cerebral palsy was the commonest presentation (90.2%) mainly presenting as diplegia (33.3%) and quadriplegia (32.4%) followed by atonic, ataxic/mixed and athetoid CP accounting for 3.9%, 3.9%, and 2.0% respectively. Birth asphyxia was the most encountered etiologic factor (32.4%) followed by prematurity (26.5%), kernicterus (12.7%) and meningoencephalitis (10.8%). Spastic quadriplegic and diplegic CP were primarily related to birth asphyxia, hemiplegic, ataxic and mixed CP to prematurity and atonic and athetoid CP to kernicterus. ÖZETAmaç: Pakistan'da serebralpalsi frekansı yüksektir ancak bu durumun daha fazla araştırılması gerekmektedir. Bu çalışmanın amacı Pakistan'da hastanede serebralpalsili çocuklar arasında klinik sunumların ve etyolojik faktörlerin değerlendirilmesidir. Materyal ve Metod: Bu çalışmaya dahil edilen 102 çocuk, Avrupa'daki Surveillance of CerebralPalsyde gözetim altında bulunan çocuklarla aynı kriterlere sahiptir ve Rawalpindi'de Silahlı kuvvetler rehabilitasyon merkezi enstitüsünde bulunmaktadır. Bulgular: 102 çocuktan 46'sı (%45.1) erkek, 56'sı (%54.9) kızdır, çocukların ortalama yaşları 5.6 ± 2.25' tir. En sık spastik serebralpalsi (%90.2) görülmektedir, bu da dipleji (%33.3), kuadriplejiyi (%32.4) takip eden 3.9% atonik, % 3.9 ataksik/karışık ve %2 atedoit CP olarak görülmektedir. Doğum asfiksisi en sık karşılaşılan etyolojik faktördür (%32.4) bunu prematürite (%26.5), kernikterus (%12.7) ve meningoensefalit (%10.8) takip etmektedir. Spastik kuadriplejik ve

show abstract

The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995-1998

Cited by 374 publications

References 32 publications

Trends in prevalence of cerebral palsy in children born with a birthweight of 2,500 g or over in Europe from 1980 to 1998

Trends in prevalence of cerebral palsy in children born with a birthweight of 2,500 g or over in Europe from 1980 to 1998

The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb

Pakistanlı Çocuklarda Serebral Palsi: Hastane Tabanlı İnceleme

Contact Info

Product

Resources

About